• Non ci sono risultati.

Genetic and process engineering for the production of protein therapeutics for the treatment of CNS disorders

N/A
N/A
Protected

Academic year: 2021

Condividi "Genetic and process engineering for the production of protein therapeutics for the treatment of CNS disorders"

Copied!
53
0
0

Testo completo

Loading

Figura

Figure 1.1. Schematic representation of CNF1 functional domains and its mechanism  of  action
Figure  1.2.  Schematic  outline  of  CNF1  therapeutic  features  in  animal  models  recapitulating  CNS  diseases
Table 1. List of Buffers and Additives Used During CNF1-H8 Stor- Stor-age and DLS Analysis at 48C
Figure 1. CNF1-H8 expression levels in E. coli BL21(DE3). Whole cell lysates were evaluated by SDS-PAGE (A) and Western blot analysis (B)
+7

Riferimenti

Documenti correlati

[r]

129 Faculty of Mathematics and Physics, Charles University in Prague, Praha, Czech Republic 130 State Research Center Institute for High Energy Physics (Protvino), NRC KI, Russia

Il progetto si propone nello specifico di avviare, attraverso la costituzione di una partnership tra enti pubblici (Università di Verona 1 , Comune di Mantova e ASL di

Finally, considering FGF-2 levels’ changes through the various time points, an overall FGF-2 circulating blood levels’ increasing trend after eight weeks of treatment was

I vantaggi di internet risiedono (i) nella possibilità, per l’utente, di costruirsi un proprio percorso di informazione attraverso l’universo ipertestuale della rete

Des recherches récentes sont présentées dans cet article, visant l’évaluation des performances de certains polymères de cellulose estérifiée dans le traitement des vins

La presente tesi ha riguardato l’ottimizzazione di matrici polimeriche solide preparate mediante liofilizzazione per il rilascio di bevacizumab nel segmento

The main experimental results as well as the potential energy surface illustrating possible reaction pathways for the formation of the observed reaction products are presented..